The Board of Directors of AMAG Pharmaceuticals, Inc. has authorized a buyback plan on January 6, 2016.
1st Jan change | Capi. | |
---|---|---|
+62.80% | 856B | |
+38.95% | 631B | |
-4.15% | 359B | |
+17.51% | 325B | |
+8.62% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.29% | 177B | |
+1.97% | 165B |
The Board of Directors of AMAG Pharmaceuticals, Inc. has authorized a buyback plan on January 6, 2016.
1st Jan change | Capi. | |
---|---|---|
+62.80% | 856B | |
+38.95% | 631B | |
-4.15% | 359B | |
+17.51% | 325B | |
+8.62% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.29% | 177B | |
+1.97% | 165B |